At a glance
ClinicalIndex Comparison Record- ✓Symptomatic heart failure NYHA Class II-IV within 3 months of entry
- ✓Left ventricular ejection fraction <35% by CMR or gated SPECT
- ✓Coronary anatomy suitable for revascularization
- ✕Primary valvular heart disease requiring valve repair or replacement
- ✕Cardiogenic shock or requiring inotropic/intra-aortic balloon support
- ✕PCI planned for CAD treatment
- ✕Acute myocardial infarction within 30 days
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
In Brief
A clinical study evaluating Coronary Artery Bypass, Modern medical management, and 2 other interventions for Cardiovascular Diseases and 4 related conditions. Completed, enrolled 319 participants.
Detailed Summary
To define the role of the assessment of myocardial viability with dobutamine echocardiography (DE) in the clinical evaluation and selection of the best treatment for a high-risk subset of patients with coronary artery disease.
Study Details
Timeline
Interventions
coronary revascularization using arterial or vein conduits
Therapies with evidence-based recommendations.
Incremental dose administration of dobutamine to elicit a contractile response of the myocardium.
All medical interventions known to improve outcomes in patients with ischemic left ventricular dysfunction.